Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes.
Yu B, Hu M, Jiang W, Ma Y, Ye J, Wu Q, Guo W, Sun Y, Zhou M, Xu Y, Wu Z, Wang Y, Lam SM, Shui G, Gu J, Li JZ, Fu Z, Gong Y, Zhou H.
Yu B, et al. Among authors: zhou h, zhou m.
Lipids Health Dis. 2023 Oct 4;22(1):166. doi: 10.1186/s12944-023-01921-0.
Lipids Health Dis. 2023.
PMID: 37794463
Free PMC article.